Thermo Fisher Scientific ...

NYSE: TMO · Real-Time Price · USD
485.13
0.34 (0.07%)
At close: Aug 14, 2025, 3:59 PM
486.60
0.30%
Pre-market: Aug 15, 2025, 06:58 AM EDT

Thermo Fisher Scientific Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 28, 2025 Mar 29, 2025 Dec 31, 2024 Sep 28, 2024 Jun 29, 2024 Mar 30, 2024 Dec 31, 2023 Sep 30, 2023 Jul 1, 2023 Apr 1, 2023 Dec 31, 2022 Oct 1, 2022 Jul 2, 2022 Apr 2, 2022 Dec 31, 2021 Oct 2, 2021 Jul 3, 2021 Apr 3, 2021
Revenue
43.21B 42.9B 42.88B 42.37B 42.35B 42.49B 42.86B 43.42B 43.52B 43.81B 44.91B 44.17B 42.82B 41.12B 39.21B 39.06B 38.25B 35.89B
Cost of Revenue
26.11B 25.5B 25.51B 25.51B 25.5B 25.72B 26.12B 26.48B 26.59B 26.56B 26.37B 24.85B 23.18B 21.53B 19.9B 19.39B 18.89B 17.69B
Gross Profit
17.1B 17.4B 17.37B 16.86B 16.85B 16.77B 16.74B 16.94B 16.93B 17.25B 18.55B 19.32B 19.64B 19.59B 19.31B 19.67B 19.36B 18.21B
Operating Income
7.94B 7.78B 7.66B 7.38B 7.44B 7.47B 7.45B 7.44B 7.23B 7.39B 8.53B 9.22B 9.81B 10.12B 10.35B 10.81B 10.85B 10.05B
Interest Income
1B 1B 1.08B 1.16B 1.13B 1.01B 879M 720M 542M 400M 272M 133M 74M 49M 43M 44M 44M 41M
Pretax Income
7.02B 6.99B 7B 6.76B 6.78B 6.51B 6.24B 6.25B 6.03B 6.48B 7.66B 7.78B 8.42B 8.6B 8.83B 9.87B 9.95B 9.15B
Net Income
6.58B 6.51B 6.34B 6.14B 6.22B 6.03B 6B 5.94B 5.72B 6.02B 6.95B 7.03B 7.44B 7.6B 7.72B 8.56B 8.6B 7.92B
Selling & General & Admin
7.75B 8.22B 8.32B 8.13B 8.09B 7.98B 7.95B 8.1B 8.27B 8.41B 8.55B 8.63B 8.36B 8.02B 7.55B 7.47B 7.17B 6.9B
Research & Development
1.41B 1.4B 1.39B 1.34B 1.32B 1.32B 1.34B 1.4B 1.43B 1.45B 1.47B 1.47B 1.47B 1.45B 1.41B 1.39B 1.33B 1.26B
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
9.16B 9.62B 9.71B 9.47B 9.4B 9.3B 9.29B 9.5B 9.7B 9.86B 10.02B 10.1B 9.83B 9.47B 8.96B 8.86B 8.51B 8.16B
Interest Expense
1.51B 1.53B 1.59B 1.65B 1.62B 1.53B 1.46B 1.29B 1.07B 890M 726M 618M 573M 547M 536M 521M 537M 552M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
35.27B 35.12B 35.22B 34.98B 34.9B 35.03B 35.41B 35.98B 36.3B 36.42B 36.39B 34.95B 33.01B 31B 28.86B 28.25B 27.4B 25.84B
Income Tax Expense
436M 472M 658M 641M 595M 519M 284M 324M 302M 448M 703M 732M 972M 993M 1.11B 1.3B 1.35B 1.23B
Shares Outstanding (Basic)
378M 378M 382.85M 382M 382M 382M 387M 386M 386M 386M 391M 392M 392M 392M 394M 394M 393M 394M
Shares Outstanding (Diluted)
378M 379M 383M 384M 383M 384M 388M 388M 388M 388M 393M 395M 394M 395M 398M 397M 396M 397M
EPS (Basic)
17.33 17.10 16.59 16.01 16.18 15.66 15.52 15.34 14.71 15.42 17.73 17.90 18.92 19.33 19.61 21.71 21.76 20.03
EPS (Diluted)
17.28 17.04 16.52 15.94 16.12 15.59 15.45 15.26 14.62 15.33 17.62 17.78 18.79 19.18 19.45 21.52 21.57 19.86
EBITDA
11.4B 11.58B 11.74B 11.69B 11.8B 11.43B 11.17B 11.04B 10.64B 10.93B 11.94B 11.75B 12.07B 12B 11.96B 12.9B 12.94B 12.08B
EBIT
8.53B 8.6B 8.63B 8.49B 8.48B 8.05B 7.76B 7.62B 7.24B 7.55B 8.56B 8.54B 9.06B 9.17B 9.37B 10.39B 10.48B 9.7B
Depreciation & Amortization
2.87B 2.98B 3.11B 3.21B 3.32B 3.38B 3.41B 3.42B 3.4B 3.38B 3.38B 3.22B 3.01B 2.83B 2.59B 2.51B 2.46B 2.37B